title: A comparison of two methods to determine the presence of high-risk HPV cervical infections.
abstract: Clinical tests for human papillomavirus (HPV) DNA require clinical validation before being offered for use by laboratories. To determine the clinical viability of a laboratory-developed test using the Invader HPV reagents (Third Wave Technologies, Madison, WI), a retrospective study was designed using 213 patient cervical cytologic samples. The results of the Invader assay were directly compared with the results obtained using the Hybrid Capture 2 High-Risk HPV assay (Digene, Gaithersburg, MD). The results of both assays were also compared with cytologic evaluation. In addition, clinical performance was evaluated using a standard-of-care approach in which colposcopically guided biopsies were done in cases where standard of care dictated, and the histologic features of the biopsy specimens were noted. The Invader-based test demonstrated a clinical sensitivity in atypical squamous cells of undetermined significance cases of 98% for cervical intraepithelial neoplasia (CIN) 2 or worse and 100% for CIN 3 or worse and a negative predictive value of 96.9% (confidence interval, 89.3%-99.6%) using data generated mostly from the use of an earlier version of reagents. These findings support the clinical and laboratory benefits of the Invader method.
authors.affiliation: Hematopathology and Flow Cytometry, Regional Medical Laboratory, Tulsa, OK 74104, USA.
authors.forename: Lawrence R
authors.initials: LR
authors.lastname: Johnson
authors.forename: Cindi R
authors.initials: CR
authors.lastname: Starkey
authors.forename: James
authors.initials: J
authors.lastname: Palmer
authors.forename: James
authors.initials: J
authors.lastname: Taylor
authors.forename: Spencer
authors.initials: S
authors.lastname: Stout
authors.forename: Stephanie
authors.initials: S
authors.lastname: Holt
authors.forename: Ryan
authors.initials: R
authors.lastname: Hendren
authors.forename: Brian
authors.initials: B
authors.lastname: Bock
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Waibel
authors.forename: Gale
authors.initials: G
authors.lastname: Tyree
authors.forename: Gerald C
authors.initials: GC
authors.lastname: Miller
mesh_terms: D002584:Cervix Uteri / Q000473:pathology / Q000821:virology*; D004279:DNA, Viral / Q000032:analysis; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000473:pathology; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D014626:Vaginal Smears; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis / Q000473:pathology
chemical_list: D004279:DNA, Viral